Cumberland Pharmaceuticals Inc

Company Snapshot
1600 West End Avenue
Nashville, TN 37203
United States
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 85
https://www.cumberlandpharma.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
$28,788,114
$27,173,795
$32,892,428
Operating Income
($6,381,595)
($7,677,420)
($5,704,929)
Net Income
($3,339,408)
($3,507,587)
($5,570,241)
2020
Gross Profit
$28,788,114
Operating Income
($6,381,595)
Net Income
($3,339,408)
2021
Gross Profit
$27,173,795
Operating Income
($7,677,420)
Net Income
($3,507,587)
2022
Gross Profit
$32,892,428
Operating Income
($5,704,929)
Net Income
($5,570,241)
The above data on Cumberland Pharmaceuticals Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
A. Kazimi
Chairman of the Board and Chief Executive Officer
$895,000
$279,800
$22,497
$1,197,297
A. Kazimi
$1,197,297
Chairman of the Board and Chief Executive Officer
James Herman
Senior Vice President and Chief Compliance Officer
$352,000
$15,540
$20,648
$388,188
James Herman
$388,188
Senior Vice President and Chief Compliance Officer
John Hamm
Senior Director, Finance and Accounting, Chief Financial Officer and Principal Accounting Officer
$231,000
$56,980
$20,378
$308,358
John Hamm
$308,358
Senior Director, Finance and Accounting, Chief Financial Officer and Principal Accounting Officer
Gordon Bernard
Independent Director
$123,500
$0
$0
$123,500
Gordon Bernard
$123,500
Independent Director
James Jones
Independent Director
$47,740
$2,740
$0
$50,480
James Jones
$50,480
Independent Director
Cumberland Pharmaceuticals Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us